KA
ABBV icon

Kooman & Associates’s AbbVie ABBV Stock Holding History

Kooman & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$820K Sell
3,133
-284
-8% -$72.8K 0.22% 25
2026
Q2 		$860K Buy
3,417
+159
+5% +$34.2K 0.23% 26
2026
Q1 		$709K Sell
3,258
-30
-0.9% -$6.66K 0.21% 25
2025
Q4 		$751K Sell
3,288
-187
-5% -$42.6K 0.22% 24
2025
Q3 		$805K Sell
3,475
-1
-0% -$204 0.25% 23
2025
Q2 		$645K Buy
3,476
+40
+1% +$7.43K 0.22% 25
2025
Q1 		$720K Buy
3,436
+25
+0.7% +$4.86K 0.26% 22
2024
Q4 		$606K Buy
3,411
+195
+6% +$35.9K 0.22% 25
2024
Q3 		$635K Sell
3,216
-14
-0.4% -$2.61K 0.23% 24
2024
Q2 		$554K Sell
3,230
-16
-0.5% -$2.65K 0.22% 24
2024
Q1 		$591K Sell
3,246
-132
-4% -$22.7K 0.25% 23
2023
Q4 		$523K Buy
3,378
+36
+1% +$5.25K 0.23% 26
2023
Q3 		$498K Buy
3,342
+13
+0.4% +$1.91K 0.25% 25
2023
Q2 		$449K Sell
3,329
-207
-6% -$30.4K 0.22% 26
2023
Q1 		$564K Buy
3,536
+15
+0.4% +$2.29K 0.3% 21
2022
Q4 		$569K Buy
+3,521
New +$540K 0.56% 21

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Kooman & Associates's ABBV Position: Q3 2026 in Review

Kooman & Associates reduced its AbbVie (ABBV) stake by 8.3% in Q3 2026, selling an estimated $72.8K and leaving 3,133 shares worth $820K. The position accounts for 0.22% of the portfolio, ranked #25.

Kooman & Associates first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. The position peaked at $860K in Q2 2026. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Kooman & Associates held 3,133 shares of AbbVie worth $820K as of Q3 2026.
  • Kooman & Associates sold 284 AbbVie shares in Q3 2026, an estimated $72.8K.
  • AbbVie made up 0.22% of Kooman & Associates's portfolio in Q3 2026, its #25 holding.
  • Kooman & Associates first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
  • Kooman & Associates's AbbVie position peaked at $860K in Q2 2026.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Kooman & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.